Rankings
▼
Calendar
INSM Q1 2023 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$65M
+22.8% YoY
Gross Profit
$51M
78.8% margin
Operating Income
-$148M
-227.2% margin
Net Income
-$160M
-245.0% margin
EPS (Diluted)
$-1.17
QoQ Revenue Growth
+10.0%
Cash Flow
Operating Cash Flow
-$146M
Free Cash Flow
-$150M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$1.6B
Stockholders' Equity
-$45M
Cash & Equivalents
$969M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$65M
$53M
+22.8%
Gross Profit
$51M
$41M
+25.6%
Operating Income
-$148M
-$90M
-64.9%
Net Income
-$160M
-$95M
-68.8%
Geographic Segments
UNITED STATES
$49M
75%
JAPAN
$13M
20%
Europe And The Rest Of The World
$3M
5%
← FY 2023
All Quarters
Q2 2023 →